SOK2 Antibody

What is SOK2 and how does it relate to SHOC2?

SOK2 is a reported synonym of the SHOC2 gene, which encodes SHOC2 leucine-rich repeat scaffold protein. The protein functions as a regulatory subunit of protein phosphatase 1 (PP1c) that serves as an M-Ras/MRAS effector and participates in MAPK pathway activation. The human version of SOK2 has a canonical length of 582 amino acid residues and a molecular weight of approximately 64.9 kilodaltons. Two isoforms of this protein have been identified, making it an important target for various experimental investigations .

What are the primary applications of SOK2 antibodies in academic research?

SOK2 antibodies are primarily utilized in several key laboratory techniques:

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative measurement of SOK2 protein levels in various sample types

• Western Blot: For detection of SOK2 protein expression and post-translational modifications

• Immunohistochemistry (IHC): For visualization of SOK2 protein localization in tissue sections

These applications enable researchers to investigate SOK2's expression patterns, protein interactions, and functional roles in various cellular contexts .

Where is SOK2 protein typically localized in cells?

SOK2 protein exhibits dual localization within cells, being present in both the nucleus and cytoplasm. This subcellular distribution pattern is significant as it suggests multiple potential functions depending on cellular context. The protein's presence in different cellular compartments may indicate roles in both cytoplasmic signaling pathways (particularly as part of the MAPK cascade) and potential nuclear functions that may influence gene expression or other nuclear processes .

How can researchers distinguish between SOK2 and other members of the leucine-rich repeat protein family?

Distinguishing SOK2 (SHOC2) from other leucine-rich repeat proteins requires careful antibody selection and validation strategies:

• Epitope targeting: Select antibodies targeting unique regions of SOK2 that don't share sequence homology with related proteins

• Cross-reactivity testing: Validate antibodies against recombinant proteins of related family members

• Knockout/knockdown controls: Use SHOC2/SOK2 knockout or knockdown samples as negative controls

• Multiple antibody approach: Employ antibodies recognizing different epitopes of SOK2 to confirm specificity

• Mass spectrometry validation: Confirm antibody target identity through immunoprecipitation followed by mass spectrometry

This methodological approach ensures experimental results accurately reflect SOK2-specific signals rather than related proteins with similar structural motifs .

What are the methodological challenges in detecting different SOK2 isoforms?

Detecting different SOK2 isoforms presents several methodological challenges:

Since two isoforms of SOK2 have been identified, researchers must carefully select antibodies capable of distinguishing between these variants or use complementary molecular techniques to confirm isoform identity when studying their differential expression and function .

How does SOK2 contribute to MAPK pathway signaling, and how can antibodies help elucidate this role?

SOK2 (SHOC2) acts as a critical scaffold protein in the MAPK pathway by:

• Functioning as a regulatory subunit for protein phosphatase 1 (PP1c)

• Mediating interactions with M-Ras/MRAS as an effector protein

• Facilitating signal transduction through the MAPK cascade

Researchers can use SOK2 antibodies to investigate these mechanisms through:

• Co-immunoprecipitation studies to identify protein-protein interactions between SOK2, PP1c, and MRAS

• Proximity ligation assays to visualize protein complexes in situ

• Phospho-specific antibodies to track activation states of pathway components

• Chromatin immunoprecipitation if SOK2 has nuclear regulatory functions

• Immunofluorescence to monitor translocation events during signaling

These approaches provide insights into how SOK2 scaffolding functions coordinate signaling events and potentially identify new therapeutic targets in pathways dysregulated in disease states .

What strategies can researchers employ to optimize antibody-based detection of low-abundance SOK2 in samples?

For detecting low-abundance SOK2 protein in biological samples, researchers should consider the following optimization strategies:

• Sample enrichment techniques:

  • Subcellular fractionation to concentrate nuclear or cytoplasmic fractions

  • Immunoprecipitation to enrich SOK2 protein before analysis

  • Column chromatography methods to reduce sample complexity

• Signal amplification methods:

  • Tyramide signal amplification for immunohistochemistry

  • Enhanced chemiluminescence substrates for Western blotting

  • Biotin-streptavidin systems for ELISA

• Detection system optimization:

  • Use of highly sensitive digital imaging systems

  • Longer exposure times with low background detection methods

  • Quantum dot conjugated secondary antibodies for increased sensitivity

• Protocol modifications:

  • Extended primary antibody incubation (overnight at 4°C)

  • Optimized blocking conditions to reduce background

  • Increased antibody concentrations with validated specificity

What are recommended protocols for using SOK2 antibodies in immunohistochemistry?

Recommended Immunohistochemistry Protocol for SOK2 Detection:

• Tissue Preparation:

  • Fix tissues in 10% neutral buffered formalin for 24-48 hours

  • Process and embed in paraffin

  • Section at 4-5 μm thickness

• Antigen Retrieval:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0) for 20 minutes

  • Allow slides to cool to room temperature (20 minutes)

• Blocking and Antibody Incubation:

  • Block endogenous peroxidase (3% H₂O₂, 10 minutes)

  • Block non-specific binding (5% normal serum, 1 hour)

  • Incubate with primary SOK2 antibody (1:100-1:500 dilution, overnight at 4°C)

  • Wash in PBS (3 × 5 minutes)

  • Incubate with appropriate secondary antibody (1 hour at room temperature)

• Detection and Visualization:

  • Apply detection system (e.g., DAB substrate)

  • Counterstain with hematoxylin

  • Dehydrate, clear, and mount

• Controls:

  • Include positive control tissue (appendix or caudate)

  • Include negative control (primary antibody omitted)

  • Consider peptide competition to confirm specificity

This protocol should be optimized based on the specific SOK2 antibody being used and the tissue type under investigation .

How should researchers optimize Western blot conditions for detecting SOK2 protein?

Optimized Western Blot Protocol for SOK2 Detection:

• Sample Preparation:

  • Extract proteins using RIPA buffer with protease/phosphatase inhibitors

  • Determine protein concentration (BCA or Bradford assay)

  • Prepare 20-40 μg protein per lane with reducing sample buffer

• Gel Electrophoresis:

  • Use 8-10% SDS-PAGE gels (optimal for 64.9 kDa SOK2 protein)

  • Run at 100V until adequate separation (approximately 1.5-2 hours)

• Transfer Conditions:

  • Transfer to PVDF membrane (wet transfer: 100V for 1 hour or 30V overnight at 4°C)

  • Verify transfer using Ponceau S staining

• Antibody Incubation:

  • Block membrane (5% non-fat dry milk or BSA in TBST, 1 hour at room temperature)

  • Incubate with primary SOK2 antibody (1:1000 dilution in blocking buffer, overnight at 4°C)

  • Wash with TBST (3 × 10 minutes)

  • Incubate with HRP-conjugated secondary antibody (1:5000 in blocking buffer, 1 hour at room temperature)

  • Wash with TBST (3 × 10 minutes)

• Detection:

  • Apply enhanced chemiluminescence substrate

  • Expose to X-ray film or use digital imaging system

  • Expected band size: approximately 65 kDa for canonical SOK2

• Controls and Validation:

  • Include positive control (tissue/cell line with known SOK2 expression)

  • Consider loading controls (β-actin, GAPDH)

  • For isoform detection, optimize gel percentage for better resolution

What controls should be included when performing experiments with SOK2 antibodies?

When conducting experiments with SOK2 antibodies, researchers should incorporate the following controls to ensure reliable and interpretable results:

• Positive Controls:

  • Tissues or cell lines with confirmed SOK2 expression (e.g., appendix or caudate tissue)

  • Recombinant SOK2 protein as a reference standard

  • Overexpression systems (transfected cells expressing SOK2)

• Negative Controls:

  • Primary antibody omission (technical negative)

  • Isotype control antibodies (matched to primary antibody)

  • SOK2 knockdown or knockout samples (if available)

  • Tissues known not to express SOK2

• Specificity Controls:

  • Peptide competition/neutralization assays

  • Use of multiple antibodies targeting different SOK2 epitopes

  • siRNA-mediated knockdown with gradient reduction

• Technical Controls:

  • Loading controls for Western blot (β-actin, GAPDH, etc.)

  • Internal staining controls for IHC (known positive structures)

  • Standard curves for quantitative assays (ELISA)

• Validation Approaches:

  • Orthogonal detection methods (mRNA expression correlation)

  • Mass spectrometry confirmation of immunoprecipitated proteins

  • Testing across multiple experimental conditions

These comprehensive controls help distinguish true SOK2 signals from potential artifacts or non-specific binding events .

What are common troubleshooting strategies for experiments involving SOK2 antibodies?

Troubleshooting Guide for SOK2 Antibody Experiments:

When encountering experimental issues, researchers should systematically evaluate each step of their protocol while maintaining careful documentation of all modifications to identify optimal conditions for SOK2 detection .

How can researchers use SOK2 antibodies to investigate MAPK pathway dysregulation in disease models?

SOK2 antibodies can be instrumental in studying MAPK pathway dysregulation through several methodological approaches:

• Comparative expression analysis: Use SOK2 antibodies to quantify expression levels across healthy versus disease tissues/cells through Western blotting and immunohistochemistry to identify altered expression patterns.

• Co-immunoprecipitation studies: Employ SOK2 antibodies to isolate protein complexes and analyze interaction partners (particularly PP1c and M-Ras) in normal versus pathological states using mass spectrometry or Western blotting of precipitated complexes.

• Proximity ligation assays: Combine SOK2 antibodies with antibodies against other MAPK pathway components to visualize and quantify protein-protein interactions in situ, allowing for spatial analysis of signaling complexes.

• Phosphorylation state analysis: Use SOK2 antibodies in combination with phospho-specific antibodies targeting downstream MAPK components to correlate SOK2 expression with pathway activation status.

• Chromatin immunoprecipitation: If SOK2 has nuclear functions, ChIP assays can reveal potential DNA binding sites or chromatin associations that might be altered in disease states.

These approaches can provide mechanistic insights into how SOK2's scaffolding functions influence MAPK signaling in various pathological conditions, potentially identifying novel therapeutic targets .

What considerations should researchers take into account when selecting SOK2 antibodies for flow cytometry applications?

When selecting SOK2 antibodies for flow cytometry applications, researchers should consider:

• Epitope accessibility: Choose antibodies targeting epitopes that remain accessible in non-denatured proteins since flow cytometry typically detects native protein conformations.

• Fluorophore selection: Select directly conjugated antibodies or appropriate secondary antibodies with fluorophores compatible with available laser/filter configurations and planned multi-parameter panels.

• Intracellular versus surface staining: Since SOK2 is primarily intracellular (nuclear and cytoplasmic), ensure proper cell permeabilization protocols are used (e.g., methanol, saponin, or commercial permeabilization kits).

• Clone validation: Verify the antibody clone has been validated specifically for flow cytometry applications, as not all IHC or Western blot-validated antibodies perform well in flow.

• Titration optimization: Perform antibody titration experiments to determine optimal concentration that maximizes signal-to-noise ratio.

• Compensation controls: Include appropriate single-stained controls for compensation when using multiple fluorophores.

• Blocking strategy: Implement effective Fc receptor blocking to reduce non-specific binding, particularly in immune cell populations.

• Fixation compatibility: Confirm antibody compatibility with fixation methods required for your experimental design.

Properly validated SOK2 antibodies for flow cytometry can enable quantitative analysis of expression levels at the single-cell level, providing insights into heterogeneity within populations and correlation with other cellular markers .

How might emerging antibody engineering technologies improve SOK2 antibody specificity and sensitivity?

Emerging antibody engineering technologies offer several promising avenues for enhancing SOK2 antibody performance:

• Phage display libraries: Generation of high-affinity recombinant antibodies through iterative selection against specific SOK2 epitopes, potentially creating reagents with improved specificity.

• Single B-cell cloning: Isolation of naturally occurring high-affinity antibodies from immunized animals to develop monoclonals with exceptional binding properties.

• Antibody fragment technologies: Development of smaller binding units (Fab, scFv, nanobodies) that may access epitopes unavailable to conventional antibodies and improve tissue penetration.

• Affinity maturation techniques: In vitro evolution methods to enhance binding affinity through directed mutagenesis of complementarity-determining regions.

• Bispecific antibody platforms: Creation of dual-targeting antibodies that recognize both SOK2 and interaction partners simultaneously for improved specificity in complex studies.

• Machine learning-guided design: Implementation of computational approaches to predict optimal binding regions and antibody structures, as suggested by recent advances in antibody engineering.

• Site-specific conjugation: Development of precisely labeled antibodies with defined fluorophore-to-antibody ratios for improved quantitative applications.

These technological advances could address current limitations in SOK2 detection by producing reagents with enhanced specificity for particular isoforms, improved signal-to-noise ratios, and better performance across multiple applications .

What potential roles might SOK2 play in disease pathogenesis that warrant further investigation with antibody-based techniques?

Based on its function as a regulatory component in the MAPK pathway, several potential roles of SOK2 (SHOC2) in disease pathogenesis merit further investigation:

• Cancer biology: As a scaffold protein in MAPK signaling, SOK2 may influence cell proliferation and survival pathways frequently dysregulated in cancer. Antibody-based tissue microarray studies could reveal expression patterns across cancer types and correlate with patient outcomes.

• Developmental disorders: Given that related scaffold proteins are implicated in developmental pathways, SOK2 might play roles in congenital abnormalities. Immunohistochemical studies in developmental tissues could elucidate spatiotemporal expression patterns.

• Neurodegenerative diseases: The notable expression in caudate tissue suggests potential roles in neurological function. Co-localization studies with markers of neurodegeneration could reveal associations with disease processes.

• Inflammatory conditions: MAPK pathways regulate immune responses, suggesting SOK2 might influence inflammatory processes. Flow cytometry with SOK2 antibodies could characterize expression in immune cell subsets during inflammation.

• Therapeutic target assessment: If SOK2 proves important in disease pathways, antibody-based proximity ligation assays could evaluate the efficacy of small molecule inhibitors targeting relevant protein-protein interactions.

These research directions would benefit from specialized antibody applications including multiplex immunofluorescence, in situ proximity ligation, and single-cell analysis techniques to fully characterize SOK2's roles in normal physiology and pathological states .